<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/01D58A80-A729-4F08-B0FF-03C1B2622320"><gtr:id>01D58A80-A729-4F08-B0FF-03C1B2622320</gtr:id><gtr:name>Moredun Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0"><gtr:id>A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0</gtr:id><gtr:name>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1AD37A82-0DC3-4A84-893C-F32A7B4EB56F"><gtr:id>1AD37A82-0DC3-4A84-893C-F32A7B4EB56F</gtr:id><gtr:name>French National Institute of Agricultural Research (INRA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4F10851E-F3F5-4F2F-8587-7EA8086F2177"><gtr:id>4F10851E-F3F5-4F2F-8587-7EA8086F2177</gtr:id><gtr:name>University of Parma</gtr:name><gtr:address><gtr:line1>Universita degli studi di Parma</gtr:line1><gtr:line2>via Universita 12</gtr:line2><gtr:postCode>43121</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:department>Institute of Life Science Medical School</gtr:department><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AC87F8BC-3044-409A-BCD0-8E29686252CD"><gtr:id>AC87F8BC-3044-409A-BCD0-8E29686252CD</gtr:id><gtr:name>Dept for Env Food &amp; Rural Affairs  DEFRA</gtr:name><gtr:address><gtr:line1>Nobel House 17 Smith Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW1P 3RJ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/01D58A80-A729-4F08-B0FF-03C1B2622320"><gtr:id>01D58A80-A729-4F08-B0FF-03C1B2622320</gtr:id><gtr:name>Moredun Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0"><gtr:id>A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0</gtr:id><gtr:name>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1AD37A82-0DC3-4A84-893C-F32A7B4EB56F"><gtr:id>1AD37A82-0DC3-4A84-893C-F32A7B4EB56F</gtr:id><gtr:name>French National Institute of Agricultural Research (INRA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4F10851E-F3F5-4F2F-8587-7EA8086F2177"><gtr:id>4F10851E-F3F5-4F2F-8587-7EA8086F2177</gtr:id><gtr:name>University of Parma</gtr:name><gtr:address><gtr:line1>Universita degli studi di Parma</gtr:line1><gtr:line2>via Universita 12</gtr:line2><gtr:postCode>43121</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/032257C1-78F0-43AC-B547-287539D86C84"><gtr:id>032257C1-78F0-43AC-B547-287539D86C84</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Sheldon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FI017240%2F1"><gtr:id>242175BA-78C2-40E1-BC9B-5BB5CA9ED6CB</gtr:id><gtr:title>Integrated systems approach for preventing uterine disease in dairy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I017240/1</gtr:grantReference><gtr:abstractText>Multi-pathogen infections of the uterus after parturition are endemic causing clinical uterine disease in 40% of dairy cattle and a further 20-40% develop subclinical disease each year. The number of animals requiring treatment is rising as milk production increases. Uterine disease causes infertility, delayed conception, disruption of ovarian cycles, involuntary culling for failure to conceive, and mortality, costing the EU dairy industry EURO1.4 billion/year. The cost to the animal is pain and suffering for several weeks. The cost to the environment is more greenhouse gas emissions, land and water degradation because more cattle have to be kept on farms to replace infertile animals. Research into uterine infection has been neglected compared with other major diseases; there are no vaccines or prevention strategies, and treatment relies on antibiotics and hormones. However, there has been an explosion of knowledge about innate and mucosal immunity in the last 10 years, which provides insights that can be exploited to prevent disease. Furthermore, our recent work has identified several potential strategies to prevent or limit this endemic disease that urgently need examining. Now is the strategic moment where concerted action between the partners is likely to have an impact on uterine disease. This project aims to translate novel strategies into potential products that limit the impact of uterine disease. We will pursue 3 objectives: 1. Refine our underpinning knowledge and tools for postpartum uterine disease in cattle. This includes refining and benchmarking our in vitro and in vivo models of disease; exploring the details of the microbes that infect the uterus, including our newly discovered endometrial pathogenic E. coli (EnPEC); and developing molecular tools to evaluate and diagnose disease. 2. Test candidate strategies to prevent or limit uterine disease using our in vitro and in vivo models. 3. Translate the best candidate strategies that prevent or limit uterine disease to pre-clinical field trials. The project addresses the first translational gap between basic science and the generation of ideas or products for animal health. We are fortunate to have support from our industrial partners, who also have the expertise to then take the results of the project to market for the benefit of all stakeholders.</gtr:abstractText><gtr:technicalSummary>Multi-pathogen infections of the uterus after parturition are endemic causing clinical uterine disease in 40% of dairy cattle and a further 20-40% develop subclinical disease each year. The number of animals requiring treatment is rising as milk production increases. Uterine disease causes infertility, delayed conception, disruption of ovarian cycles, involuntary culling for failure to conceive, and mortality, costing the EU dairy industry EURO1.4 billion/year. The cost to the animal is pain and suffering for several weeks. The cost to the environment is more greenhouse gas emissions, land and water degradation because more cattle have to be kept on farms to replace infertile animals. This project aims to translate novel strategies into potential products that limit the impact of uterine disease. We will pursue 3 objectives: 1. Refine our underpinning knowledge and tools for postpartum uterine disease in cattle. 2. Test candidate strategies to prevent or limit uterine disease using our in vitro and in vivo models. 3. Translate the best candidate strategies that prevent or limit uterine disease to pre-clinical field trials.</gtr:technicalSummary><gtr:potentialImpactText>Fit to EMIDA goals 1. Supports EU collaboration at a strategic point in research development for a neglected microbial disease of livestock. 2. Coordinated transnational approach provides a critical research mass to accelerate progress to prevent uterine disease, which costs the EU EURO1.4 billion each year. 3. Reducing the incidence and severity of a common infection by vaccination or regulation of mucosal immunity, will: a. Improve cattle health, fertility and productivity b. Enhance the sustainability of EU dairy farming c. Reduce the environmental footprint of dairy cattle d. Improve animal welfare e. Increase European animal health industry competiveness f. Translate basic science to products that address an endemic disease of livestock g. Develop novel diagnostic tools for subclinical disease h. Reduce the reliance on antimicrobial and hormone treatments 4. Step up durable reproductive disease research in the EU. 5. Bring substantial funding to the EU from Pfizer's group of world-leading pharmaceutical companies.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>386994</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Pfizer Animal Health</gtr:department><gtr:description>iPUD</gtr:description><gtr:id>67CCE0F5-1E83-48FB-9239-3AB54C09DA27</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moredun Research Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>iPUD</gtr:description><gtr:id>ED8BDB70-680C-4B7D-84F3-AF80025F7318</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research (INRA)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>iPUD</gtr:description><gtr:id>775698DB-49F0-48F5-999B-23F487459BC3</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>iPUD</gtr:description><gtr:id>21965EB5-0925-45A7-AAA6-A9E855981BC3</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Parma</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Open innovation</gtr:description><gtr:id>A0AD543F-ACDB-4133-A73F-61E5BBE525C2</gtr:id><gtr:impact>Paper to be published</gtr:impact><gtr:partnerContribution>Viral biotype provision and testing.</gtr:partnerContribution><gtr:piContribution>ERASMUS collaboration on viral sensing in the endometrium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Veterinary Medicine Glasgow</gtr:department><gtr:description>iPUD</gtr:description><gtr:id>2DE7A41B-6FBD-4F10-A91F-3B099FB6BD7D</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florida</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>iPUD</gtr:description><gtr:id>8F52AEA0-014C-4982-9305-9E3DF2347F80</gtr:id><gtr:impact>See https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:impact><gtr:partnerContribution>Microbiology, clinical trials</gtr:partnerContribution><gtr:piContribution>Innate immunity in the endometrium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research (INRA)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INRA Rennes Centre</gtr:department><gtr:description>Supplying Trueperella pyogenes isolates</gtr:description><gtr:id>091F7FAF-131F-42E5-9F1B-D9B97717897C</gtr:id><gtr:impact>In vivo animal model (Confidential IP)</gtr:impact><gtr:partnerContribution>We are conducting collaborative projects, and seeking further funding in some cases.</gtr:partnerContribution><gtr:piContribution>We supply fully sequenced isolates of our clinical isolates of Trueperella pyogenes for research in vitro and in vivo</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Uo3A</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1D8EA036-66AA-4B8F-BE63-9B89696D62D7</gtr:id><gtr:impact>University of the third age meeting - talk on science and the science of infertility

I was asked to give further talks to local lay audiences</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Two products are in pre-clinical trials and will move to clinical trails Q4 2014
A patent was applied for by Zoetis Inc.
Clinical trials confirmed the effectiveness of the compounds.
There is an issue about the cost of compound relative to the ability of farmers to pay for a product.
Zoetis are taking commercial decisions.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>600C532F-BA79-4E9C-940F-8C33DA4950D3</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention provides a method for preventing, treating, delaying
the onset or lessening the severity of bacterial uterine disease, including metritis,
endometritis and pelvic inflammatory disease, in mammals, such as cattle,
sheep, goats, dogs, and cats.</gtr:description><gtr:id>A0CB5587-4EE0-4BA8-A6AC-5F8C05AAE2B4</gtr:id><gtr:impact>Product Operating Plan within Zoetis Inc.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>US62/076,687</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>THE USE OF STATINS IN TREATING BACTERIAL UTERINE DISEASE</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The iPUD project worked as an integrated collaboration between academic groups and a large industrial partner (Pfizer Animal Health, which was divested from Pfizer Inc. during the lifetime of the project to form the company Zoetis).
Main Activities
In Work Package 1 (WP1), we refined underpinning knowledge about innate immunity and inflammation in the bovine endometrium and immune cells. We developed an ex vivo model to study bovine endometrium, and refined our in vitro culture systems for endometrial cells and immune cells. We sequenced several bacterial genomes and made important discoveries about the ecology and virulence factors of the microbes. We developed for the first time a robust and repeatable in vivo model of uterine disease in lactating cows, which is used for product development. We are finalising the diagnostic gene panels for healthy and diseased endometrium.
In WP2 we used the models developed in WP1 to identify candidate strategies to limit the severity of uterine disease. We first used our ex vivo and in vitro models to screen 49 active molecules, across multiple mechanisms of action. Following extensive testing in 3 countries, one of the mechanisms of action was selected to go forward to the animal model, along with a prototype vaccine. The remaining mechanisms of action were published or shared by open innovation. The animal model was used to evaluate active molecules from the candidate mechanism of action and the vaccine. The animal model was used to test efficacy against uterine disease, and both approaches have gone to pre-clinical studies in WP3.
In WP3 we translated our selected two strategies to pre-clinical trials. Multiple in vivo and in vitro studies were completed to evaluate safety and prepare data for regulatory authorities for approval for a field study. Both strategies are now in early product development in industry, and the industrial partner has already committed twice the original agreed budget to this work. The field study is scheduled for the end of 2014 pending site determination limitations.
The overarching WP4 was where we established the framework for international collaboration including a Project Management Board and an External Advisory Group. We held 14 meetings of the whole project group, including 8 meetings in-person over 2 days each, in France. 

International Collaboration
There was a wide range of real interaction between research groups, as evidenced in multiple joint publications (see Section 5). This included exchange of bacteria, exchange of biological samples and active molecules, and collaborative research projects. Added value included training of staff within the EU and the formation of a firm foundation for our research, as evidenced by team members winning 3 further grants within the EU.</gtr:description><gtr:exploitationPathways>Confidential clinical trials of 2 products. These trials were successful and Zoetis are taking commercial decisions.</gtr:exploitationPathways><gtr:id>79475477-3700-4317-B359-82C9861ED14D</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors><gtr:url>https://sites.google.com/site/professormartinsheldon/projects/ipud-project</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BE7E234-3572-4153-9F3A-FBAD27CC8A11"><gtr:id>6BE7E234-3572-4153-9F3A-FBAD27CC8A11</gtr:id><gtr:title>Mechanisms linking bacterial infections of the bovine endometrium to disease and infertility.</gtr:title><gtr:parentPublicationTitle>Reproductive biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2db5c13470b6f92d4e2f64b758973fae"><gtr:id>2db5c13470b6f92d4e2f64b758973fae</gtr:id><gtr:otherNames>Carneiro LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1642-431X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA1B5405-AAB6-4D5A-BD7E-DAAF22DF2EA5"><gtr:id>EA1B5405-AAB6-4D5A-BD7E-DAAF22DF2EA5</gtr:id><gtr:title>Draft Genome Sequence of Escherichia coli MS499, Isolated from the Infected Uterus of a Postpartum Cow with Metritis.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fd3317309d7bf5da4e9c4aa752ffaff"><gtr:id>1fd3317309d7bf5da4e9c4aa752ffaff</gtr:id><gtr:otherNames>Goldstone RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8A6EA77-A907-4932-B5D6-6456EFB8A11D"><gtr:id>C8A6EA77-A907-4932-B5D6-6456EFB8A11D</gtr:id><gtr:title>Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0f45d3185383fca5e4f87279d5d2064"><gtr:id>e0f45d3185383fca5e4f87279d5d2064</gtr:id><gtr:otherNames>Healey GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C71E15B-5D2B-43DA-8552-A88350196CCA"><gtr:id>5C71E15B-5D2B-43DA-8552-A88350196CCA</gtr:id><gtr:title>Ovarian steroids do not affect bovine endometrial cytokine or chemokine responses to Escherichia coli or LPS in vitro.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19a2263378cee99aa552b9e7fa233cfd"><gtr:id>19a2263378cee99aa552b9e7fa233cfd</gtr:id><gtr:otherNames>Saut JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C9F8273-76EA-4FC4-984A-70084FBAC4A1"><gtr:id>7C9F8273-76EA-4FC4-984A-70084FBAC4A1</gtr:id><gtr:title>Genes and environmental factors that influence disease resistance to microbes in the female reproductive tract of dairy cattle.</gtr:title><gtr:parentPublicationTitle>Reproduction, fertility, and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4f15d090e2f758bd90c95313a63469d"><gtr:id>c4f15d090e2f758bd90c95313a63469d</gtr:id><gtr:otherNames>Sheldon IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1031-3613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6CF6CDF-18D3-4851-AE0D-094B4CCA23D8"><gtr:id>A6CF6CDF-18D3-4851-AE0D-094B4CCA23D8</gtr:id><gtr:title>Analysis of STAT1 expression and biological activity reveals interferon-tau-dependent STAT1-regulated SOCS genes in the bovine endometrium.</gtr:title><gtr:parentPublicationTitle>Reproduction, fertility, and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e7d3e522426be7ee5c58e19fb0ff949"><gtr:id>6e7d3e522426be7ee5c58e19fb0ff949</gtr:id><gtr:otherNames>Vitorino Carvalho A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1031-3613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFA5DEDD-1BE9-4C28-BFC0-DC43C417C29C"><gtr:id>EFA5DEDD-1BE9-4C28-BFC0-DC43C417C29C</gtr:id><gtr:title>Signal transducer and activator of transcription-3 licenses Toll-like receptor 4-dependent interleukin (IL)-6 and IL-8 production via IL-6 receptor-positive feedback in endometrial cells.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01dc97191a336d896bbf85c2c90db3de"><gtr:id>01dc97191a336d896bbf85c2c90db3de</gtr:id><gtr:otherNames>Cronin JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/413D3623-B67F-463D-97E0-4177B6EECCB9"><gtr:id>413D3623-B67F-463D-97E0-4177B6EECCB9</gtr:id><gtr:title>Differential endometrial cell sensitivity to a cholesterol-dependent cytolysin links Trueperella pyogenes to uterine disease in cattle.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9e861c1f988076b4d5680f25b1eee8c"><gtr:id>a9e861c1f988076b4d5680f25b1eee8c</gtr:id><gtr:otherNames>Amos MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2ACC447A-015E-4B34-90E5-9047E57A1477"><gtr:id>2ACC447A-015E-4B34-90E5-9047E57A1477</gtr:id><gtr:title>Polarized Epithelial Cells Secrete Interleukin 6 Apically in the Bovine Endometrium.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69e2d5830e6492220fd13a13c1e9301f"><gtr:id>69e2d5830e6492220fd13a13c1e9301f</gtr:id><gtr:otherNames>Healy LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D9E39FE-9ADA-475A-AC21-C1416D6B4775"><gtr:id>3D9E39FE-9ADA-475A-AC21-C1416D6B4775</gtr:id><gtr:title>Detection of Pathogens in Blood for Diagnosis of Sepsis and Beyond.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4f15d090e2f758bd90c95313a63469d"><gtr:id>c4f15d090e2f758bd90c95313a63469d</gtr:id><gtr:otherNames>Sheldon IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F294004A-2190-4500-93C6-03D9BFF0D801"><gtr:id>F294004A-2190-4500-93C6-03D9BFF0D801</gtr:id><gtr:title>Tethered bilayer membranes as a complementary tool for functional and structural studies: The pyolysin case.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05d3950d0043486709d504e765380dfd"><gtr:id>05d3950d0043486709d504e765380dfd</gtr:id><gtr:otherNames>Preta G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFB47433-C9A7-4D11-9D0E-6AB40D9810AA"><gtr:id>BFB47433-C9A7-4D11-9D0E-6AB40D9810AA</gtr:id><gtr:title>Glucose Availability and AMP-Activated Protein Kinase Link Energy Metabolism and Innate Immunity in the Bovine Endometrium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e4eabeae42859a78bf411bef8061611"><gtr:id>4e4eabeae42859a78bf411bef8061611</gtr:id><gtr:otherNames>Turner ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/871C833E-158F-4235-88A8-945F5AEBDC9B"><gtr:id>871C833E-158F-4235-88A8-945F5AEBDC9B</gtr:id><gtr:title>Innate immunity and the sensing of infection, damage and danger in the female genital tract.</gtr:title><gtr:parentPublicationTitle>Journal of reproductive immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4f15d090e2f758bd90c95313a63469d"><gtr:id>c4f15d090e2f758bd90c95313a63469d</gtr:id><gtr:otherNames>Sheldon IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0165-0378</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A73E964-CE62-40A9-8431-5E823E10F9F3"><gtr:id>3A73E964-CE62-40A9-8431-5E823E10F9F3</gtr:id><gtr:title>Draft Genome Sequence of Trueperella pyogenes, Isolated from the Infected Uterus of a Postpartum Cow with Metritis.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fd3317309d7bf5da4e9c4aa752ffaff"><gtr:id>1fd3317309d7bf5da4e9c4aa752ffaff</gtr:id><gtr:otherNames>Goldstone RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CDBDAFF-8583-4040-8198-990F9B81DFF2"><gtr:id>7CDBDAFF-8583-4040-8198-990F9B81DFF2</gtr:id><gtr:title>SOCS genes expression during physiological and perturbed implantation in bovine endometrium.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd96eff3d88b284e5aee9571d4ce3bc6"><gtr:id>dd96eff3d88b284e5aee9571d4ce3bc6</gtr:id><gtr:otherNames>Carvalho AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F551FF9-8C74-4CCA-AACF-68FD8AC5FF84"><gtr:id>8F551FF9-8C74-4CCA-AACF-68FD8AC5FF84</gtr:id><gtr:title>Innate immunity and inflammation of the bovine female reproductive tract in health and disease.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4f15d090e2f758bd90c95313a63469d"><gtr:id>c4f15d090e2f758bd90c95313a63469d</gtr:id><gtr:otherNames>Sheldon IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/792AF857-C458-45E0-B355-6776597D85A7"><gtr:id>792AF857-C458-45E0-B355-6776597D85A7</gtr:id><gtr:title>Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e4eabeae42859a78bf411bef8061611"><gtr:id>4e4eabeae42859a78bf411bef8061611</gtr:id><gtr:otherNames>Turner ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AE53E297-8849-4FC9-A502-A1C58BE5A0F7"><gtr:id>AE53E297-8849-4FC9-A502-A1C58BE5A0F7</gtr:id><gtr:title>Peripheral blood leukocytes of cows with subclinical endometritis show an altered cellular composition and gene expression.</gtr:title><gtr:parentPublicationTitle>Theriogenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ecfa0a1238d7eb183de909bbecd3f2d"><gtr:id>7ecfa0a1238d7eb183de909bbecd3f2d</gtr:id><gtr:otherNames>D?vel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0093-691X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3E5960D-BBBF-4622-BDE0-E289530A91D1"><gtr:id>A3E5960D-BBBF-4622-BDE0-E289530A91D1</gtr:id><gtr:title>Short communication: Glutamine modulates inflammatory responses to lipopolysaccharide in ex vivo bovine endometrium.</gtr:title><gtr:parentPublicationTitle>Journal of dairy science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/947002f1a29d32c3258d9c44ad9400aa"><gtr:id>947002f1a29d32c3258d9c44ad9400aa</gtr:id><gtr:otherNames>Noleto PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-0302</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I017240/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>